REGENXBIO
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Biotechnology
業務概覽 Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeuticproteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
公司地址 9804 Medical Center Drive, Rockville, MD, USA, 20850
電話號碼 +1 240 552-8181
傳真號碼 --
公司網頁 https://www.regenxbio.com
員工數量 371
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Craig Malzahn Executive Vice President, Product Development and Chief Technology Officer -- 14/04/2026
Mr. Mitchell Chan Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer -- 14/04/2026
Mr. Stephen Pakola, M.D. Executive Vice President and Chief Medical Officer 美元 543.99K 14/04/2026
Dr. Olivier Danos, PhD Executive Vice President and Chief Scientific Officer -- 14/04/2026
Mr. Patrick J. Christmas Executive Vice President, Chief Strategy Officer and Chief Legal Officer 美元 520.90K 14/04/2026
Mr. Curran Simpson Director, President and Chief Executive Officer 美元 665.51K 14/04/2026
 
董事會成員
董事會 職務 更新日期
Ms. Jennifer Zachary Independent Director 14/04/2026
Dr. Jean Bennett, M.D.,Pd.D Independent Director 14/04/2026
Mr. Allan M. Fox Independent Director 14/04/2026
Dr. Alexandra Glucksmann, PhD Independent Director 14/04/2026
Mr. Daniel Tasse Lead Independent Director 14/04/2026
Mr. George V. Migausky Independent Director 14/04/2026
Dr. David C. Stump,M.D. Independent Director 14/04/2026
Mr. Curran Simpson Director, President and Chief Executive Officer 14/04/2026
Mr. Kenneth T. Mills Chairman of the Board 14/04/2026
Dr. Argeris N. Karabelas, PhD Independent Director 14/04/2026
 
所屬ETF (更新日期: 02/05/2026 04:56)
代號 名稱 佔比% ▼ 持有日期
DXUVDimensional US Vector Equity ETF0.003%29/04/2026
TMFXMotley Fool Next ETF0.002%29/04/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0004%31/05/2023
HDGProShares Hedge Replication0.0001%29/04/2026
RESMColumbia Research Enhanced Small Cap ETF0.0001%29/04/2026
RBProshares Russell 2000 Dynamic BufferETF0.00003%29/04/2026
AIEQAI Powered Equity ETF<0.000001%24/05/2023
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%06/03/2026
AVSCAvantis US Small Cap Equity ETF<0.000001%19/02/2026
AVUSAvantis US Equity ETF<0.000001%04/02/2026
BMEDiShares Health Innovation Active ETF<0.000001%26/02/2026
DFATDimensional US Targeted Value ETF<0.000001%06/01/2026
DFAUDimensional US Core Equity Market ETF<0.000001%27/04/2026
EWSCInvesco S&P SmallCap 600® Equal Wt ETF<0.000001%20/03/2023
IJRiShares Core S&P Small-Cap ETF<0.000001%06/03/2026
IJSiShares S&P Small-Cap 600 Value ETF<0.000001%06/03/2026
IJTiShares S&P Small-Cap 600 Growth ETF<0.000001%06/03/2026
ISCBiShares Morningstar Small-Cap ETF<0.000001%03/03/2026
ISCViShares Morningstar Small-Cap Value ETF<0.000001%04/03/2026
MFIGMotley Fool Innovative Growth Factor ETF<0.000001%02/04/2026
  1    2   3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.